Myovant Sciences’ Founding Shareholder Roivant Sciences, and Sumitomo Dainippon Pharma Enter into a Memorandum of Understanding to Create a Broad Strategic Alliance September 6, 2019 - NYSE Companies 0 » View More News for September 06, 2019
